Calpain inhibition protects spinal motoneurons from the excitotoxic effects of AMPA in vivo

Neurochemical Research

Volumn 33, Issue 8, 2008, Pages 1428-1434

  Corona, Juan Carlos ^a   Tapia, Ricardo ^a  

^a INSTITUTO DE FISIOLOGÍA CELULAR   (Mexico)

Author keywords

AMPA receptor; Amyotrophic lateral sclerosis; Calcium; Calpain; Motoneuron death

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; CALCIUM ION; CALPAIN; CHOLINE ACETYLTRANSFERASE; CRESYL VIOLET; DYE; LEUPEPTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; EXCITOTOXICITY; IMMUNOHISTOCHEMISTRY; LUMBAR SPINAL CORD; MALE; MICRODIALYSIS; MOTOR DYSFUNCTION; NERVE CELL NECROSIS; NERVE DEGENERATION; NONHUMAN; PARALYSIS; PRIORITY JOURNAL; PROTECTION; RAT; SPINAL CORD MOTONEURON;

ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; CALPAIN; CYSTEINE PROTEINASE INHIBITORS; EXCITATORY AMINO ACID AGONISTS; LEUPEPTINS; MALE; MOTOR NEURONS; RATS; RATS, WISTAR; ROTAROD PERFORMANCE TEST; SPINAL CORD;

RATTUS;

EID: 46249106545     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-007-9559-7     Document Type: Article

References (36)

1. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O'Regan JP, Deng HX et al (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362:59-62
2. Carriedo SG, Yin HZ, Weiss JH (1996) Motor neurons are selectively vulnerable to AMPA/kainate receptor-mediated injury in vitro. J Neurosci 16:4069-4079
3. 2+-permeable AMPA receptors and selective vulnerability of motor neurons. J Neurol Sci 180:29-34
4. Corona JC, Tapia R (2004) AMPA receptor activation, but not the accumulation of endogenous extracellular glutamate, induces paralysis and motor neuron death in rat spinal cord in vivo. J Neurochem 89:988-997
5. Vandenberghe W, Robberecht W, Brorson JR (2000) AMPA receptor calcium permeability, GluR2 expression, and selective motoneuron vulnerability. J Neurosci 20:123-132
6. 2+ determine motoneuron vulnerability in rat spinal cord in vivo. Neuropharmacology 52:1219-1228
7. Corona JC, Tovar-y-Romo LB, Tapia R (2007) Glutamate excitotoxicity and therapeutic targets for amyotrophic lateral sclerosis. Expert Opin Ther Targets 11:1415-1428
8. Shields DC, Ray SK, Gantt-Wilford G, Banik NL (1998) Calpain expression varies among different rat and bovine central nervous system regions. J Neurosci Res 53:482-489
9. Bi X, Chen J, Baudry M (1998) Calpain-mediated proteolysis of GluR1 subunits in organotypic hippocampal cultures following kainic acid treatment. Brain Res 781:355-357
10. Guttmann RP, Sokol S, Baker DL, Simpkins KL, Dong Y, Lynch DR (2002) Proteolysis of the N-methyl-d-aspartate receptor by calpain in situ. J Pharmacol Exp Ther 302:1023-1030
11. Araujo IM, Verdasca MJ, Leal EC, Bahr BA, Ambrosio AF, Carvalho AP, Carvalho CM (2004) Early calpain-mediated proteolysis following AMPA receptor activation compromises neuronal survival in cultured hippocampal neurons. J Neurochem 91:1322-1331
12. Ray SK, Banik NL (2003) Calpain and its involvement in the pathophysiology of CNS injuries and diseases: therapeutic potential of calpain inhibitors for prevention of neurodegeneration. Curr Drug Targets CNS Neurol Disord 2:173-189
13. Araujo IM, Carvalho CM (2005) Role of nitric oxide and calpain activation in neuronal death and survival. Curr Drug Targets CNS Neurol Disord 4:319-324
14. Banik NL, Shields DC, Ray S, Davis B, Matzelle D, Wilford G, Hogan EL (1998) Role of calpain in spinal cord injury: effects of calpain and free radical inhibitors. Ann NY Acad Sci 844:131-137
15. McCollum AT, Jafarifar F, Lynn BC, Agu RU, Stinchcomb AL, Wang S, Chen Q, Guttmann RP (2006) Inhibition of calpain-mediated cell death by a novel peptide inhibitor. Exp Neurol 202:506-513
16. Schumacher PA, Siman RG, Fehlings MG (2000) Pretreatment with calpain inhibitor CEP-4143 inhibits calpain I activation and cytoskeletal degradation, improves neurological function, and enhances axonal survival after traumatic spinal cord injury. J Neurochem 74:1646-1655
17. Di Stasi AM, Gallo V, Ceccarini M, Petrucci TC (1991) Neuronal fodrin proteolysis occurs independently of excitatory amino acid-induced neurotoxicity. Neuron 6:445-454
18. Caner H, Collins JL, Harris SM, Kassell NF, Lee KS (1993) Attenuation of AMPA-induced neurotoxicity by a calpain inhibitor. Brain Res 607:354-356
19. Rami A, Krieglstein J (1993) Protective effects of calpain inhibitors against neuronal damage caused by cytotoxic hypoxia in vitro and ischemia in vivo. Brain Res 609:67-70
20. Rami A, Ferger D, Krieglstein J (1997) Blockade of calpain proteolytic activity rescues neurons from glutamate excitotoxicity. Neurosci Res 27:93-97
21. 2+ entry via AMPA/KA receptors and excitotoxicity in cultured cerebellar Purkinje cells. J Neurosci 14:187-197
22. Ding D, Stracher A, Salvi RJ (2002) Leupeptin protects cochlear and vestibular hair cells from gentamicin ototoxicity. Hear Res 164:115-126
23. Harding DI, Greensmith L, Connold AL, Vrbova G (1996) Stabilizing neuromuscular contacts increases motoneuron survival after neonatal nerve injury in rats. Neuroscience 70:799-805
24. Kieran D, Greensmith L (2004) Inhibition of calpains, by treatment with leupeptin, improves motoneuron survival and muscle function in models of motoneuron degeneration. Neuroscience 125:427-439
25. Salazar P, Montiel T, Brailowsky S, Tapia R (1994) Decrease of glutamate decarboxylase activity after in vivo cortical infusion of γ-aminobutyric acid. Neurochem Int 24:363-368
26. Massieu L, Morales-Villagrán A, Tapia R (1995) Accumulation of extracellular glutamate by inhibition of its uptake is not sufficient for inducing neuronal damage: an in vivo microdialysis study. J Neurochem 64:2262-2272
27. Morales-Villagrán A, Tapia R (1996) Preferential stimulation of glutamate release by 4-aminopyridine in rat striatum in vivo. Neurochem Int 28:35-40
28. Loureiro-Dos-Santos NE, Reis RA, Kubrusly RC, de Almeida OM, Gardino PF, de Mello MC, de Mello FG (2001) Inhibition of choline acetyltransferase by excitatory amino acids as a possible mechanism for cholinergic dysfunction in the central nervous system. J Neurochem 77:1136-1144
29. Nagata Y, Okuya M, Watanabe R, Honda M (1982) Regional distribution of cholinergic neurons in human spinal cord transections in the patients with and without motor neuron disease. Brain Res 244:223-229
30. Kato T (1989) Choline acetyltransferase activities in single spinal motor neurons from patients with amyotrophic lateral sclerosis. J Neurochem 52:636-640
31. Oda Y, Imai S, Nakanishi I, Ichikawa T, Deguchi T (1995) Immunohistochemical study on choline acetyltransferase in the spinal cord of patients with amyotrophic lateral sclerosis. Pathol Int 45:933-939
32. Oda Y (1999) Choline acetyltransferase: the structure, distribution and pathologic changes in the central nervous system. Pathol Int 49:921-937
33. Virgo L, de Belleroche J, Rossi M, Steiner TJ (1992) Characterisation of the distribution of choline acetyltransferase messenger RNA in human spinal cord and its depletion in motor neurone disease. J Neurol Sci 112:126-132
34. 2+ exchanger in excitotoxicity. Cell 120:275-285
35. Wootz H, Hansson I, Korhonen L, Lindholm D (2006) XIAP decreases caspase-12 cleavage and calpain activity in spinal cord of ALS transgenic mice. Exp Cell Res 312:1890-1898
36. Ueyama H, Kumamoto T, Fujimoto S, Murakami T, Tsuda T (1998) Expression of three calpain isoform genes in human skeletal muscles. J Neurol Sci 155:163-169